TOKYO/SEOUL -- Imbalance in COVID-19 vaccine supply is deepening around the world. The U.S., EU and other nations that produce and export vaccines have surpluses totaling more than 150 million doses, while shortages have caused delays in vaccination in many countries in Asia.
Datawatch
Supply imbalance leaves 150m doses of COVID vaccine unused
Makers scramble to meet demand; situation may worsen if booster shots needed
